Barclays Maintains Overweight on Xylem, Raises Price Target to $159
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and raises the price target from $154 to $159.
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and raises the price target from $154 to $159.